Skip to content

commd7 Gene Expression in ALL

The Copper Metabolism MURR1 Domain 7 (COMMD7) Gene Expression in Acute Lymphoblastic Leukemia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05592470
Enrollment
102
Registered
2022-10-24
Start date
2022-11-30
Completion date
2024-11-30
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALL

Keywords

COMMD7 , ALL

Brief summary

* study the expression pattern of COMMD7 gene in acute lymphoblastic leukemia. * investigate correlation between the expression level of COMMD7 gene with other diagnostic parameters and prognosis in ALL .

Detailed description

Acute lymphoblastic leukemia (ALL) is a neoplastic disorder of lymphoid progenitor cells characterized by diverse cytogenetic and molecular abnormalities with peaks of prevalence for 2-5-year-old patients and those older than 50. Treatment strategies using risk-adapted chemotherapy cure more than 80% of childhood cases, but around 20 to 30% relapse developing serious complications including death.( 1) In the past decade, the available treatments for patients with acute lymphoblastic leukemia (ALL) have rapidly expanded, in parallel with an increased understanding of the genomic features that impact the disease biology and clinical outcomes.(2) The copper metabolism MURR1 domain (COMMD) protein family involved in tumor development and progression in several types of human cancer, but little is known about the function of COMMD proteins in hematological malignancy. (3) COMMD7, a member of the COMMD, which is located on chromosome 20q11.21, has been reported associated with tumor progression in human solid cancers \[4\]. COMMD7 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) cells, associated with poor prognosis. \[5\]. Another study revealed that COMMD7-overexpressed hepatocellular carcinoma (HCC) cells promoted the proliferation of naïve HCC cells (6) A recent study was found that high expression of COMMD7 is a potential biomarker for adverse outcomes and poor prognosis in AML. (7) . However, to date, the expression of COMMD7 in acute lymphoblastic leukemia and its prognostic value remain unclear.

Interventions

DIAGNOSTIC_TESTReverse transcription-quantitative polymerase chain reaction (RT-qPCR).

Reverse transcription-quantitative polymerase chain reaction on bone marrow aspirates to detect The expression pattern of COMMD7 gene in acute lymphoblastic leukemia

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Patients newly diagnosed with acute lymphoblastic leukemia , male or female at any age.

Exclusion criteria

* history of anti-neoplastic therapy, such as chemotherapy or radiotherapy. * Any other types of cancers. * Any clinically systemic acute or chronic inflammatory disease/s within one months.

Design outcomes

Primary

MeasureTime frameDescription
The expression pattern of COMMD7 gene in acute lymphoblastic leukemiaBASELINEReverse transcription-quantitative polymerase chain reaction (RT-qPCR) TO DETECT EXPRESSION pattern in ALL

Secondary

MeasureTime frame
Correlation between the expression level of COMMD7 GENE with other diagnostic parameters and prognosis in ALLbaseline

Contacts

Primary Contactmarwa saad mohamed, master
qmarwa_1989@yahoo.com0201003860750
Backup Contactsohair mohamed ahmed, doctoral
Sohairmohamed2013@gmail.com01223163678

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026